Showing results (201-210 of 236) with videos related to
Sort By:
Pageof 24
Journal of Leukocyte Biology|October 19, 2012
Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5Hamid Salimi, Michael Roche, Nicholas Webb, et al.Journal of Virology|February 25, 2026
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferationJared Stern, Rory A Shepherd, Youry Kim, et al.The Journal of Infectious Diseases|October 16, 2021
Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral TherapyJared Stern, Ajantha Solomon, Ashanti Dantanarayana, et al.Journal of Virology|December 20, 2019
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4<sup>+</sup> T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and MaintainedMichael Roche, Carolin Tumpach, Jori Symons, et al.Viruses|July 29, 2023
Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNACarolin Tumpach, Ajantha Rhodes, Youry Kim, et al.Virology|June 24, 2010
An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopesJasminka Sterjovski, Michael Roche, Melissa J Churchill, et al.Scientific Reports|February 26, 2015
Reliable genotypic tropism tests for the major HIV-1 subtypesKieran Cashin, Lachlan R Gray, Katherine L Harvey, et al.Journal of Virus Eradication|October 28, 2025
The impact of acute stress on the HIV reservoir: a prospective interventional trialJared Stern, Michael Roche, Rory Shepherd, et al.Journal of Virology|March 27, 2009
Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brainLachlan Gray, Michael Roche, Melissa J Churchill, et al.AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.Pageof 24